Eugeania Burch

Statistics

Publications

Citations

222

H-Index

Active since

2019

Affiliations

National Institutes of Health(Current)

National Institute of Allergy and Infectious Diseases

Eugeania Burch is an author at National Institutes of Health specializing in infectious diseases, antibody therapeutic efficacy, and immunogenicity of therapeutic antibodies.

Publications per year

2019–2022

Publications

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study

Martin R. Gaudinski, Emily E. Coates, Laura Novik et al. · The Lancet · 2019 · 128 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +14

Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial

Joseph P. Casazza, Evan M. Cale, Sandeep Narpala et al. · Nature Medicine · 2022 · 94 citations · Full text

Pharmacy, Immunology, Infectious Diseases +14

1–2 of 2